VERTEX PHARMACEUTICALS INC / MA Other Non-current Liabilities 2010-2026 | VRTX
Beta
What is VERTEX PHARMACEUTICALS INC / MA's current other non-current liabilities?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual other non-current liabilities for 2025 was $1.27B, a 25.12% increase from 2024. VERTEX PHARMACEUTICALS INC / MA other non-current liabilities for the quarter ending March 31, 2026 was $1.26B.
What was VERTEX PHARMACEUTICALS INC / MA's other non-current liabilities in 2024?
VERTEX PHARMACEUTICALS INC / MA annual other non-current liabilities for 2024 was $1.01B, a 15.60% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's other non-current liabilities in 2023?
VERTEX PHARMACEUTICALS INC / MA annual other non-current liabilities for 2023 was $877.7M, a 27.98% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year other non-current liabilities CAGR?
VERTEX PHARMACEUTICALS INC / MA other non-current liabilities grew at a compound annual growth rate (CAGR) of 63.58% from FY2020 to FY2025, going from $108.4M to $1.27B over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+63.6%
FY2020
$108.4M
→
FY2025
$1.27B
10111213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.27B | +25.1% | 10-K |
| FY2024 | $1.01B | +15.6% | 10-K |
| FY2023 | $877.7M | +28.0% | 10-K |
| FY2022 | $685.8M | +126.1% | 10-K |
| FY2021 | $303.3M | +179.8% | 10-K |
| FY2020 | $108.4M | +9.5% | 10-K |
| FY2019 | $99.0M | -9.0% | 10-K |
| FY2018 | $108.9M | +291.9% | 10-K |
| FY2017 | $27.8M | -3.2% | 10-K |
| FY2016 | $28.7M | -9.7% | 10-K |
| FY2015 | $31.8M | +46.4% | 10-K |
| FY2014 | $21.7M | +87.3% | 10-K |
| FY2013 | $11.6M | -16.6% | 10-K |
| FY2012 | $13.9M | +90.8% | 10-K |
| FY2011 | $7.3M | +221.7% | 10-K |
| FY2010 | $2.3M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →